Efficient clinical trial supply depends on reliable, compliant importation and Qualified Person (QP) oversight.

Our MIA (IMP) services provide end-to-end management of Investigational Medicinal Product importation and certification across the EU, ensuring every batch meets GMP and Regulatory requirements before release to trial sites.

Our experienced QPs oversee certification, documentation, and supply chain governance, coordinating with sponsors, CMOs, depots, and clinical sites.

We remove the operational and regulatory complexity of IMP logistics, keeping your studies compliant, supplied, and on schedule.

The EU MIA (IMP) Licence extends our capabilities and strengthens our quality service offerings by being able to:

• Import and QP certify IMPs, meaning we create a seamless and compliant pathway for provision of your product for clinical trial use.
• Verify QP certification for IMPs imported, supporting the provision of your product to EU clinical trial sites, including logistical support via our partners.
• Reduce vendor complexity whilst enhancing your products quality and compliance.
• Support complex and innovative therapies from medicinal drugs to ATMPs.